Medical Marijuana’s HempMeds Brazil Now Has Three Medical Indications Approved as Prescriptions

Medical Marijuana, Inc.’s Hemp-Based Cannabidiol (CBD) Oil Products Cost Being 100% Subsidized by the Brazilian Government for Three Indications: Epilepsy, Parkinson’s and Chronic Pain

Medical Marijuana, Inc.’s (OTC Pink:MJNA) cannabidiol (CBD) hemp oil – a legal U.S. cannabis product shipping to all 50 states – is creating global demand and a new business category for export. HempMeds Brasil™ has developed a portfolio of nine products for export into the Latin American prescription drug markets, of which three indications are approved and the full cost paid by the Brazilian Government.

To date, for HempMeds Brasil™ the three indications approved for export from the U.S. to Brazil are: epilepsyParkinson’s disease and chronic pain, with several more serious health conditions expected to be added over the coming quarter. Currently, Brazil is the world’s 7...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.